{"filing":{"accession_number":"0001178913-26-003741","cik":"0001574565","ticker":"EVGN","company_name":"Evogene Ltd.","form":"6-K","filing_date":"2026-07-31","report_date":"2026-07-31","primary_document":"zk2635808.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326003741/zk2635808.htm"},"events":[{"id":22374,"run_id":20237,"accession_number":"0001178913-26-003741","anchor_item_number":"EX-99.4","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.9,"summary":"Evogene held a contested 2026 Annual General Meeting on September 4, 2026, with a proxy contest involving competing director slates from the Board and activist shareholders (Pure Capital), along with shareholder votes on capital structure amendments including authorization for a reverse share split (1-for-2 to 1-for-15) and increase in authorized share capital. The Board issued an open letter defending its strategic direction and recommending shareholders vote for the Board's nominees while disregarding the activist shareholders' slate.","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-07-31","form":"6-K","submitted_at":null,"items":[{"id":22294,"accession_number":"0001178913-26-003741","item_number":"EX-99.1","item_title":"exhibit_99-1.htm","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This is a notice of annual general meeting of shareholders for Evogene Ltd., a routine governance disclosure. While the agenda includes director elections (Proposal 1), shareholder approval of capital structure amendments (Proposal 2), a reverse share split framework (Proposal 3), and auditor re-appointment (Proposal 4), the document itself is a procedural notice and invitation to vote rather than disclosure of a discrete governance event. The notice does not announce results of voting, appointment decisions, or compensation arrangements—it solicits shareholder input on pending matters. This is administrative governance disclosure typical of foreign private issuers' annual meeting notices, not a material event affecting investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22295,"accession_number":"0001178913-26-003741","item_number":"EX-99.2","item_title":"exhibit_99-2.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"This is a proxy statement for Evogene's 2026 Annual General Meeting of Shareholders, furnishing governance matters including director elections (with a contested slate from Pure Capital shareholders), authorization for a reverse share split (1-for-2 to 1-for-15), increase in authorized share capital, and auditor re-appointment. The contested director election and reverse share split authorization are material governance and capital structure decisions that would affect a reasonable investor's assessment of the company's direction and shareholder value.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22296,"accession_number":"0001178913-26-003741","item_number":"EX-99.3","item_title":"exhibit_99-3.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":false,"confidence":0.25,"reasoning":"This exhibit is a proxy statement and proxy card for Evogene's 2026 Annual General Meeting scheduled for September 4, 2026. It solicits shareholder votes on four proposals: board re-election (with competing slates), share capital increase, reverse share split framework, and auditor re-appointment. However, this is the proxy solicitation document itself, not the results of a vote. The filing date (July 31, 2026) is before the meeting date (September 4, 2026), so no vote results are yet available. This is a governance disclosure related to an upcoming shareholder meeting, not a report of voting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22297,"accession_number":"0001178913-26-003741","item_number":"EX-99.4","item_title":"exhibit_99-4.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"This is a Board-issued open letter responding to a Schedule 13D filing and shareholder request to replace the majority of the Board at an upcoming Annual General Meeting. The letter describes the Board's transformation initiatives, defends its strategic direction, and recommends shareholders vote for the Board's director nominees (Resolution 1(a)) and disregard the activist shareholders' nominees (Resolution 1(b)). This is a governance event—specifically a proxy contest or shareholder vote matter—that does not fit the narrower categories of exec_appointment, exec_departure, or exec_compensation, making governance_other the appropriate classification. The matter is material because a proxy contest involving replacement of the majority of the Board would significantly affect investor assessment of the company's leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22294,"accession_number":"0001178913-26-003741","item_number":"EX-99.1","item_title":"exhibit_99-1.htm","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This is a notice of annual general meeting of shareholders for Evogene Ltd., a routine governance disclosure. While the agenda includes director elections (Proposal 1), shareholder approval of capital structure amendments (Proposal 2), a reverse share split framework (Proposal 3), and auditor re-appointment (Proposal 4), the document itself is a procedural notice and invitation to vote rather than disclosure of a discrete governance event. The notice does not announce results of voting, appointment decisions, or compensation arrangements—it solicits shareholder input on pending matters. This is administrative governance disclosure typical of foreign private issuers' annual meeting notices, not a material event affecting investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-07-31"},{"id":22295,"accession_number":"0001178913-26-003741","item_number":"EX-99.2","item_title":"exhibit_99-2.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"This is a proxy statement for Evogene's 2026 Annual General Meeting of Shareholders, furnishing governance matters including director elections (with a contested slate from Pure Capital shareholders), authorization for a reverse share split (1-for-2 to 1-for-15), increase in authorized share capital, and auditor re-appointment. The contested director election and reverse share split authorization are material governance and capital structure decisions that would affect a reasonable investor's assessment of the company's direction and shareholder value.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-07-31"},{"id":22296,"accession_number":"0001178913-26-003741","item_number":"EX-99.3","item_title":"exhibit_99-3.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":false,"confidence":0.25,"reasoning":"This exhibit is a proxy statement and proxy card for Evogene's 2026 Annual General Meeting scheduled for September 4, 2026. It solicits shareholder votes on four proposals: board re-election (with competing slates), share capital increase, reverse share split framework, and auditor re-appointment. However, this is the proxy solicitation document itself, not the results of a vote. The filing date (July 31, 2026) is before the meeting date (September 4, 2026), so no vote results are yet available. This is a governance disclosure related to an upcoming shareholder meeting, not a report of voting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-07-31"},{"id":22297,"accession_number":"0001178913-26-003741","item_number":"EX-99.4","item_title":"exhibit_99-4.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"This is a Board-issued open letter responding to a Schedule 13D filing and shareholder request to replace the majority of the Board at an upcoming Annual General Meeting. The letter describes the Board's transformation initiatives, defends its strategic direction, and recommends shareholders vote for the Board's director nominees (Resolution 1(a)) and disregard the activist shareholders' nominees (Resolution 1(b)). This is a governance event—specifically a proxy contest or shareholder vote matter—that does not fit the narrower categories of exec_appointment, exec_departure, or exec_compensation, making governance_other the appropriate classification. The matter is material because a proxy contest involving replacement of the majority of the Board would significantly affect investor assessment of the company's leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:09:55.152505+00:00","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-07-31"}]}